Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgery and sentinel lymph node biopsy.

Mark B Faries1, Donald L Morton

  • 1Division of Surgical Oncology and the Roy E. Coats Research Laboratories, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA 90404, USA. fariesm@jwci.org

Seminars in Oncology
|December 18, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tryptophan degradation by intestinal Bacteroides induces anti-tumor immunity and limits melanoma growth.

bioRxiv : the preprint server for biology·2026
Same author

ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma.

Annals of surgical oncology·2026
Same author

Clinical Stage II Melanoma: Is There a "Simple Trick" to Significantly Improve Event-Free Survival?

Annals of surgical oncology·2025
Same author

International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma.

Annals of surgical oncology·2025
Same author

Health-related Quality of Life and hospital costs of Finnish melanoma patients participating in the second Multicenter Selective Lymphadenectomy Trial (MSLT-II).

Acta oncologica (Stockholm, Sweden)·2025
Same author

NRF-1 transcription factor regulates expression of an innate immunity checkpoint, CD47, during melanomagenesis.

Frontiers in immunology·2025
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Sentinel node (SN) biopsy is crucial for melanoma staging and prognosis in intermediate-thickness tumors. Ongoing trials evaluate if SN biopsy alone is sufficient for thin melanoma without further lymph node surgery.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Dermatology

Background:

  • Surgery is essential for managing melanoma, including primary tumors and metastases.
  • Sentinel node (SN) biopsy is a standard minimally invasive technique for detecting regional metastasis in intermediate-thickness melanoma.

Purpose of the Study:

  • To evaluate the role and impact of SN biopsy in melanoma management.
  • To assess the prognostic significance and survival impact of SN biopsy in melanoma patients.
  • To explore the utility of SN biopsy in thin melanoma and as a model for studying melanoma-induced immunosuppression.

Main Methods:

  • Review of current standards of care and ongoing clinical trials.
  • Analysis of the role of SN biopsy in determining prognosis and survival.

Related Experiment Videos

  • Investigation of SN biopsy as a model for melanoma immunosuppression studies.

    • Main Results:

    • SN biopsy is pivotal for prognosis and survival in intermediate-thickness melanoma.
    • The role of SN biopsy in thin melanoma is still under evaluation.
    • SN biopsy serves as a model for studying melanoma-induced immunosuppression.

    Conclusions:

    • SN biopsy is a key tool in melanoma staging and prognosis, particularly for intermediate-thickness tumors.
    • Further research and ongoing trials are needed to define the role of SN biopsy in thin melanoma and its potential to replace completion lymphadenectomy in select cases.